Source: University of South Florida Health
Date: November 15, 2005
Summary:
An experimental treatment that spares disability from acute stroke may be delivered much later than the current three-hour treatment standard -- a potential advance needed to benefit more stroke victims. Researchers at the University of South Florida found that human umbilical cord blood cells administered to rats two days following a stroke greatly curbed the brain's inflammatory response, reducing the size of the stroke and resulting in greatly improved recovery.
